Related Experiment Video
Updated: Dec 26, 2025

08:15
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
858
SGLT2 inhibitors: β blockers for the kidney?
1Division of Endocrinology, University of Toronto, St Michael's Hospital, ON, Canada.
The Lancet. Diabetes & Endocrinology
|September 25, 2016
Abstract
No abstract available in PubMed .

